A long-term retrospective cohort-based risk-benefit analysis of augmenting total cumulative I-131 activity to 37GBq in differentiated thyroid cancer patients with skeletal metastases.

Sivasankar Kanankulam VelliangiriSanjana BallalMadhav Prasad YadhavMadhavi TripathiSwayamjeet SatapathyChandrasekhar Bal

Published in: PloS one (2023)

For better survival outcomes, cumulative I-131 activity upto 37GBq could be administered with acceptable toxicity to DTC patients with skeletal metastases.

Keyphrases

oxidative stress
cross sectional